190 related articles for article (PubMed ID: 32887355)
21. Distinct Pattern of Microgliosis in the Olfactory Bulb of Neurodegenerative Proteinopathies.
Kohl Z; Schlachetzki JC; Feldewerth J; Hornauer P; Münch M; Adame A; Riemenschneider MJ; Winkler J; Masliah E
Neural Plast; 2017; 2017():3851262. PubMed ID: 28409032
[TBL] [Abstract][Full Text] [Related]
22. Testing Hippocampal Memory in Prodromal Dementia with Lewy Bodies.
Bussè C; Caffarra P; Rossi A; Zorzi G; Fragiacomo F; Camporese G; Pompanin S; Di Bernardo GA; Cagnin A
J Alzheimers Dis; 2018; 64(2):349-353. PubMed ID: 29914032
[TBL] [Abstract][Full Text] [Related]
23. Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies.
Lemstra AW; de Beer MH; Teunissen CE; Schreuder C; Scheltens P; van der Flier WM; Sikkes SA
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):113-118. PubMed ID: 27794030
[TBL] [Abstract][Full Text] [Related]
24. The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis.
Donaghy PC; McKeith IG
Alzheimers Res Ther; 2014; 6(4):46. PubMed ID: 25484925
[TBL] [Abstract][Full Text] [Related]
25. Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease.
Malek-Ahmadi M; Beach TG; Zamrini E; Adler CH; Sabbagh MN; Shill HA; Jacobson SA; Belden CM; Caselli RJ; Woodruff BK; Rapscak SZ; Ahern GL; Shi J; Caviness JN; Driver-Dunckley E; Mehta SH; Shprecher DR; Spann BM; Tariot P; Davis KJ; Long KE; Nicholson LR; Intorcia A; Glass MJ; Walker JE; Callan M; Curry J; Cutler B; Oliver J; Arce R; Walker DG; Lue LF; Serrano GE; Sue LI; Chen K; Reiman EM
PLoS One; 2019; 14(6):e0217566. PubMed ID: 31237877
[TBL] [Abstract][Full Text] [Related]
26. Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies.
van Steenoven I; van der Flier WM; Scheltens P; Teunissen CE; Lemstra AW
Alzheimers Res Ther; 2019 Oct; 11(1):83. PubMed ID: 31601267
[TBL] [Abstract][Full Text] [Related]
27. One year follow-up of parkinsonism in dementia with Lewy bodies.
Ballard C; O'Brien J; Swann A; Neill D; Lantos P; Holmes C; Burn D; Ince P; Perry R; McKeith I
Dement Geriatr Cogn Disord; 2000; 11(4):219-22. PubMed ID: 10867448
[TBL] [Abstract][Full Text] [Related]
28. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
Beach TG; White CL; Hladik CL; Sabbagh MN; Connor DJ; Shill HA; Sue LI; Sasse J; Bachalakuri J; Henry-Watson J; Akiyama H; Adler CH;
Acta Neuropathol; 2009 Feb; 117(2):169-74. PubMed ID: 18982334
[TBL] [Abstract][Full Text] [Related]
29. Verbal and visuospatial deficits in dementia with Lewy bodies.
Johnson DK; Morris JC; Galvin JE
Neurology; 2005 Oct; 65(8):1232-8. PubMed ID: 16247050
[TBL] [Abstract][Full Text] [Related]
30. Visual texture agnosia in dementia with Lewy bodies and Alzheimer's disease.
Oishi Y; Imamura T; Shimomura T; Suzuki K
Cortex; 2018 Jun; 103():277-290. PubMed ID: 29673784
[TBL] [Abstract][Full Text] [Related]
31. Dementia with Lewy bodies: reclassification of pathological subtypes and boundary with Parkinson's disease or Alzheimer's disease.
Iseki E
Neuropathology; 2004 Mar; 24(1):72-8. PubMed ID: 15068176
[TBL] [Abstract][Full Text] [Related]
32. Prodromal dementia with Lewy bodies.
Donaghy PC; O'Brien JT; Thomas AJ
Psychol Med; 2015 Jan; 45(2):259-68. PubMed ID: 25066469
[TBL] [Abstract][Full Text] [Related]
33. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
Jellinger KA; Korczyn AD
BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
[TBL] [Abstract][Full Text] [Related]
34. Gray matter atrophy in dementia with Lewy bodies with and without concomitant Alzheimer's disease pathology.
van der Zande JJ; Steenwijk MD; Ten Kate M; Wattjes MP; Scheltens P; Lemstra AW
Neurobiol Aging; 2018 Nov; 71():171-178. PubMed ID: 30149288
[TBL] [Abstract][Full Text] [Related]
35. Psychopathology at initial diagnosis in dementia with Lewy bodies versus Alzheimer disease: comparison of matched groups with autopsy-confirmed diagnoses.
Rockwell E; Choure J; Galasko D; Olichney J; Jeste DV
Int J Geriatr Psychiatry; 2000 Sep; 15(9):819-23. PubMed ID: 10984728
[TBL] [Abstract][Full Text] [Related]
36. Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.
Toledo JB; Gopal P; Raible K; Irwin DJ; Brettschneider J; Sedor S; Waits K; Boluda S; Grossman M; Van Deerlin VM; Lee EB; Arnold SE; Duda JE; Hurtig H; Lee VM; Adler CH; Beach TG; Trojanowski JQ
Acta Neuropathol; 2016 Mar; 131(3):393-409. PubMed ID: 26721587
[TBL] [Abstract][Full Text] [Related]
37. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.
Iranzo A; Tolosa E; Gelpi E; Molinuevo JL; Valldeoriola F; Serradell M; Sanchez-Valle R; Vilaseca I; Lomeña F; Vilas D; Lladó A; Gaig C; Santamaria J
Lancet Neurol; 2013 May; 12(5):443-53. PubMed ID: 23562390
[TBL] [Abstract][Full Text] [Related]
38. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
Jellinger KA
J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
[TBL] [Abstract][Full Text] [Related]
39. Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families.
Tsuang DW; Dalan AM; Eugenio CJ; Poorkaj P; Limprasert P; La Spada AR; Steinbart EJ; Bird TD; Leverenz JB
Arch Neurol; 2002 Oct; 59(10):1622-30. PubMed ID: 12374501
[TBL] [Abstract][Full Text] [Related]
40. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
